Jasmine C

Affordable Relief for Rheumatoid Arthritis: Biosimilars Prove Just as Effective as Original Drugs

Arthritis

Affordable Relief for Rheumatoid Arthritis: Biosimilars Prove Just as Effective as Original Drugs

What did the research discover? Researchers examined biosimilar drugs as a cost-effective alternative to biologic disease-modifying anti-rheumatic drugs (DMARDs) for rheumatoid arthritis (RA). Biosimilars of adalimumab, etanercept, infliximab, and rituximab have been approved in the U.S. and Europe, offering comparable safety and effectiveness to their reference biologics. Key findings

By Jasmine C